U-Blot® CD19 & CD28 Bispecific Antibody (RG-6333)Cat. No. WA3940Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® CD19 & CD28 Bispecific Antibody (RG-6333)Cat. No. WA3940
U-Blot® Human FAP & CD3E Antibody (Iv0277)Cat. No. WA3939
U-Blot® Mouse LAG3 & PD-1 Bispecific Antibody (Iv0273)Cat. No. WA3938
U-Blot® Mouse EGFR & CD3e Bispecific Antibody (Iv0272)Cat. No. WA3937
U-Blot® Human EDB & CD3E Bispecific Antibody (Iv0268)Cat. No. WA3936
U-Blot® HCV E1 & E2 Antibody (HC33.4)Cat. No. WA3935
U-Blot® HCV E1 & E2 Complex Antibody (AR5A)Cat. No. WA3934
U-Blot® HCV E1 & E2 Complex Antibody (AR4A)Cat. No. WA3933
U-Blot® Human ALK-1 & VEGF Bispecific Antibody (Iv0250)Cat. No. WA3932
U-Blot® Fluorescein & mCD47 Bispecific Antibody (Iv0235)Cat. No. WA3931
U-Blot® Fluorescein & mPD-L1 Bispecific Antibody (Iv0234)Cat. No. WA3930
U-Blot® Fluorescein & mCD3e Bispecific Antibody (Iv0233)Cat. No. WA3929